Option Care Health (NASDAQ:OPCH) Shares Unloaded Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently sold shares of Option Care Health, Inc. (NASDAQ:OPCH). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Option Care Health stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Option Care Health Stock Up 4.3%

Shares of OPCH stock traded up $1.29 on Tuesday, reaching $31.21. 1,049,703 shares of the stock were exchanged, compared to its average volume of 1,925,416. Option Care Health, Inc. has a twelve month low of $22.29 and a twelve month high of $35.53. The company has a market capitalization of $4.95 billion, a price-to-earnings ratio of 24.96, a PEG ratio of 1.74 and a beta of 0.88. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The business’s 50 day moving average price is $27.74 and its 200 day moving average price is $29.41.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in OPCH. Envestnet Asset Management Inc. raised its stake in Option Care Health by 14.9% during the first quarter. Envestnet Asset Management Inc. now owns 184,180 shares of the company’s stock worth $6,437,000 after acquiring an additional 23,849 shares during the period. Cerity Partners LLC bought a new position in shares of Option Care Health during the first quarter worth about $303,000. CWM LLC grew its holdings in Option Care Health by 245.1% in the 1st quarter. CWM LLC now owns 3,375 shares of the company’s stock worth $118,000 after buying an additional 2,397 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Option Care Health in the 1st quarter worth about $6,636,000. Finally, Avantax Advisory Services Inc. acquired a new stake in shares of Option Care Health during the first quarter worth approximately $494,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Buying and Selling at Option Care Health

In other news, Director Norman L. Wright bought 3,411 shares of the stock in a transaction dated Tuesday, September 9th. The stock was bought at an average cost of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the stock in a transaction on Monday, November 3rd. The stock was purchased at an average cost of $25.98 per share, with a total value of $987,240.00. Following the purchase, the director directly owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This represents a 10.12% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.64% of the company’s stock.

Wall Street Analysts Forecast Growth

OPCH has been the topic of several research reports. TD Cowen lowered their price objective on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research report on Monday, November 3rd. Wall Street Zen downgraded Option Care Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. JMP Securities set a $36.00 price objective on Option Care Health in a research report on Friday, October 31st. Citizens Jmp decreased their price target on Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a research note on Friday, October 31st. Finally, Cowen initiated coverage on Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating on the stock. Nine research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $35.67.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.